Top 10 Immuno-Oncology Startups

Top 10 Immuno-Oncology Startups

The 20 Hottest Pipeline Drugs to Watch in 2019

The 20 Hottest Pipeline Drugs to Watch in 2019

German Merck boosts autoimmune BTK inhibitor chase

German Merck boosts autoimmune BTK inhibitor chase

7 drugmakers to watch on Q3 earnings

7 drugmakers to watch on Q3 earnings

Does CAR-T Therapy Have a Payment Problem?

By many standards, and certainly by the way the media covers it and industry promotes it, immuno-oncology therapies using CAR-T are revolutionizing cancer treatments. But what if, as the saying goes, they threw a revolution and nobody came? Or more precisely, what if they threw a revolution and no one was willing to pay for … Continue reading Does CAR-T Therapy Have a Payment Problem?

CAR T Cells: Engineering Patients’ Immune Cells to Treat Their Cancers

  For years, the foundations of cancer treatment were surgery, chemotherapy, and radiation therapy. Over the last two decades, targeted therapies like imatinib (Gleevec®)and trastuzumab (Herceptin®)—drugs that target cancer cells by homing in on specific molecular changes seen primarily in those cells—have also cemented themselves as standard treatments for many cancers. But over the past several years, immunotherapy—therapies that enlist and strengthen … Continue reading CAR T Cells: Engineering Patients’ Immune Cells to Treat Their Cancers

Drugs Carried in Cellular ‘Backpacks’ Help T-Cells to Destroy Tumours

  Researchers have designed nanoparticles that can be attached to T-cells and release T-cell-stimulating molecules called cytokines, that activate T-cells to attack nearby tumour cells. Programming the body’s immune system to attack cancer cells has had promising results for treating blood cancers such as lymphoma and leukaemia. This tactic has proven more challenging for solid … Continue reading Drugs Carried in Cellular ‘Backpacks’ Help T-Cells to Destroy Tumours

Global Trends in Oncology – 2018

    All you need to know about the rapidly evolving cancer treatment landscape and its economic impact. All the recent launches, highly anticipated new immuno-therapies and future trends. A complete review of the oncology pharmaceutical market in 2018 Cancer is the second most common cause of death in the US and it accounts for … Continue reading Global Trends in Oncology – 2018